{"id":38974,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/employment-agreement-bio-technology-general-corp-and-dov.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"employment-agreement-bio-technology-general-corp-and-dov","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/compensation\/employment-agreement-bio-technology-general-corp-and-dov.html","title":{"rendered":"Employment Agreement &#8211; Bio-Technology General Corp. and Dov Kanner"},"content":{"rendered":"<pre>                              EMPLOYMENT AGREEMENT\n\n            AGREEMENT made as of January 23, 2000, among BIO-TECHNOLOGY GENERAL\nCORP., a Delaware corporation with an office at 70 Wood Avenue South, Iselin,\nNew Jersey 08830 ('BTG'), BIO-TECHNOLOGY GENERAL (ISRAEL) LTD., an Israeli\ncorporation and a wholly-owned subsidiary of BTG having an office at Kiryat\nWeizmann, Rehovot, Israel 76326 ('BTG-ISRAEL' and, together with BTG, the\n'Company') and Dov Kanner, residing at 1 Shkolnick Street, Rehovot 76209, Israel\n(the 'Executive').\n\n                              W I T N E S S E T H :\n\n            WHEREAS, the Company desires that Executive be employed to serve in\na senior executive capacity with the Company, and Executive desires to be so\nemployed by the Company, upon the terms and conditions herein set forth.\n\n            NOW, THEREFORE, in consideration of the premises and of the mutual\npromises, representations and covenants herein contained, the parties hereto\nagree as follows:\n\n      1. EMPLOYMENT.\n\n            The Company hereby employs Executive and Executive hereby accepts\nsuch employment, subject to the terms and conditions herein set forth. Executive\nshall hold the office of Senior Vice President of BTG and General Manager of\nBTG-Israel reporting to the Chief Executive Officer of BTG.\n\n      2. TERM.\n\n            The initial term of employment under this Agreement shall begin on\nthe date hereof (the 'Employment Date') and shall continue for a period of two\n(2) years from that date, subject to prior termination in accordance with the\nterms hereof. Thereafter, this Agreement shall automatically be renewed for\nsuccessive two-year terms unless either party shall give the other ninety (90)\ndays prior written notice of its intent not to renew this Agreement.\n\n      3. COMPENSATION.\n\n            As compensation for the employment services to be rendered by\nExecutive hereunder, including all services as an officer or director of the\nCompany and any of its subsidiaries, the Company agrees to pay, or cause to be\npaid, to Executive, and Executive agrees to accept, payable in equal\ninstallments in accordance with Company practice, an initial annual salary of\n$180,000.\n\n\n\nExecutive's annual salary hereunder for the remaining years of employment shall\nbe determined by the Board of Directors of BTG in its sole discretion. In\naddition, Executive shall be entitled to bonuses from time to time in such\namounts as may be determined by the Board of Directors of BTG in its sole\ndiscretion. Such bonus may be paid, in the sole discretion of the Board of\nDirectors, in cash, shares of BTG Common Stock, options to purchase shares of\nBTG Common Stock or any combination thereof.\n\n      4. EXPENSES.\n\n            The Company shall pay or reimburse Executive, upon presentment of\nsuitable vouchers, for all reasonable business and travel expenses which may be\nincurred or paid by Executive in connection with his employment hereunder,\nincluding without limitation telephone and facsimile expenses at his home.\nExecutive shall comply with such restrictions and shall keep such records as the\nCompany may deem necessary, as set forth in its written policies.\n\n      5. OTHER BENEFITS.\n\n            Executive shall be entitled, as long as he remains an employee of\nthe Company, to such vacations (which shall be at least four weeks per annum)\nand to participate in and receive any other benefits customarily provided by the\nCompany to its senior management personnel (including any profit sharing,\npension, short and long-term disability insurance, hospital, major medical\ninsurance and group life insurance plans in accordance with the terms of such\nplans) and including stock option and\/or stock purchase plans, all as determined\nfrom time to time by the Board of Directors of BTG. Unused annual vacations may\nnot be carried over to other years without the consent of the Chief Executive\nOfficer of BTG; provided that Executive may carry over from year to year all\nunused vacation accrued through December 31, 1999..\n\n            BTG-Israel shall provide Executive with a company car and the other\nbenefits provided Israeli employees by BTG-Israel as long as Executive remains\nan employee of the Company. In addition, as long as he remains an employee of\nthe Company, BTG-Israel shall reimburse to Executive all income taxes paid by\nExecutive in respect of BTG-Israel providing Executive with a company car and\nreimbursing Executive for his telephone and facsimile expenses at his home. All\nfringe benefits provided under Israeli law, such as Directors Insurance and\nKeren Hishtalmut, shall be paid using 100% of Executive's salary for calculation\npurposes after the date hereof.\n\n      6. STOCK OPTIONS.\n\n            (a) The Compensation and Stock Option Committee of the BTG Board of\nDirectors (the 'Committee') has approved the grant to Executive of a\nnon-qualified stock option to purchase 100,000 shares of BTG Common Stock (the\n'Options'), at an exercise price per share equal to the fair market value of BTG\nCommon Stock on the date hereof, such Options to become exercisable as\n\n\n                                       2-\n\n\nto 25,000 shares on the first anniversary date of this Agreement and as to an\nadditional 25,000 shares on each successive anniversary date of this Agreement.\n\n            (b) Any future grant of stock options shall be subject to such terms\nas the Committee in its sole discretion shall specify at the time of grant.\n\n      7. DUTIES.\n\n            (a) Executive shall be responsible for the overall management of\nBTG-Israel, shall assist in acquisitions and commercial activities and perform\nsuch other duties and functions as the Chief Executive Officer of BTG shall from\ntime to time determine and Executive shall comply in the performance of his\nduties with the policies of, and be subject to, the direction of the Board of\nDirectors of BTG. If Executive shall be elected or appointed as a director of\nBTG or BTG-Israel during the term of this Agreement, he will serve in such\ncapacity without further compensation. Executive shall, without further\ncompensation, serve as an executive officer and director of any other subsidiary\nof the Company (collectively the 'subsidiary' or 'subsidiaries') specified by\nthe Chief Executive Officer of BTG and, in the performance of such duties,\nExecutive shall comply with the policies of the Board of Directors of each such\nsubsidiary.\n\n            (b) Executive agrees to devote his entire working time, attention\nand energies to the performance of the business of the Company and of any of its\nsubsidiaries by which he may be employed; and Executive shall not, directly or\nindirectly, alone or as a member of any partnership or other organization, or as\nan officer, director or employee of any other corporation, partnership or other\norganization, be actively engaged in or concerned with any other duties or\npursuits which interfere with the performance of his duties hereunder, or which,\neven if non-interfering, may be, in the reasonable determination of the Board of\nDirectors of BTG in its sole discretion, inimical, or contrary, to the best\ninterests of the Company, except those duties or pursuits specifically\nauthorized by the BTG Board of Directors.\n\n            (c) All fees, compensation or commissions received by Executive\nduring the term of this Agreement for personal services (including, but not\nlimited to, commissions and compensation received as a fiduciary or a director,\nand fees for lecturing and teaching) rendered at the request of the Company\nshall be paid to the Company when received by Executive, except those fees that\nthe BTG Board of Directors determines may be kept by Executive. This provision\nshall not be construed to prevent Executive from investing or trading in\nnonconflicting investments as he sees fit for his own account, including real\nestate, stocks, bonds, securities, commodities or other forms of investments.\n\n      8. TERMINATION OF EMPLOYMENT; EFFECT OF TERMINATION.\n\n            (a) Executive's employment hereunder may be terminated at any time\nupon written notice from BTG to Executive:\n\n\n                                       3-\n\n\n            (i) upon the determination by the Board of Directors of BTG that\n      Executive's performance of his duties has not been fully satisfactory for\n      any reason which would not constitute justifiable cause (as hereinafter\n      defined) upon ninety (90) days' prior written notice to Executive; or\n\n            (ii) upon the determination by the Board of Directors of BTG that\n      there is justifiable cause (as hereinafter defined) for such termination\n      upon ten (10) days' prior written notice to Executive.\n\n            (b) Executive's employment shall terminate upon:\n\n            (i) the death of Executive; or\n\n            (ii) the 'disability' of Executive (as hereinafter defined pursuant\n      to subsection (c) herein) pursuant to subsection (f) hereof.\n\n            (c) For the purposes of this Agreement, the term 'disability' shall\nmean the inability of Executive, due to illness, accident or any other physical\nor mental incapacity, substantially to perform his duties in a normal manner for\na period of three (3) consecutive months or for a total of six (6) months\n(whether or not consecutive) in any twelve (12) month period during the term of\nthis Agreement as reasonably determined by the Board of Directors of BTG after\nexamination of Executive by an independent physician reasonably acceptable to\nExecutive.\n\n            (d) For the purposes hereof, the term 'justifiable cause' shall mean\nand be limited to: any willful breach by Executive of the performance of any of\nhis duties pursuant to this Agreement; Executive's conviction (which, through\nlapse of time or otherwise, is not subject to appeal) of any crime or offense\ninvolving money or other property of the Company or its subsidiaries or which\nconstitutes a felony in the jurisdiction involved; Executive's performance of\nany act or his failure to act, for which it is determined by independent counsel\nretained by the Board (which may be counsel for the Company), after due inquiry\nin which Executive is given the opportunity to be heard, that if he were\nprosecuted and convicted, a crime or offense involving money or property of the\nCompany or its subsidiaries, or which would constitute a felony in the\njurisdiction involved, would have occurred; any unauthorized disclosure by\nExecutive to any person, firm or corporation other than the Company, its\nsubsidiaries and its and their directors, officers and employees, of any\nconfidential information or trade secret of the Company or any of its\nsubsidiaries; any attempt by Executive to secure any improper personal profit in\nconnection with the business of the Company or any of its subsidiaries; the\nfailure by Executive to devote his full time to the affairs of the Company and\nits subsidiaries; Executive's pursuit of activities which in the reasonable\ndetermination of the Board of Directors of BTG are inimical, or contrary, to the\nbest interests of the Company; the engaging by Executive in any business other\nthan the business of the Company and its subsidiaries which interferes with the\nperformance of his duties hereunder; or Executive's repeated and willful failure\nto follow the instructions of the Board of Directors or the Chief Executive\nOfficer of BTG (other than instructions \n\n\n                                       4-\n\n\nwhich are illegal or improper) where such conduct shall not have ceased or\noffense cured within 30 days following written warning from the Company. Upon\ntermination of Executive's employment for justifiable cause, this Agreement\nshall terminate immediately and Executive shall not be entitled to any amounts\nor benefits hereunder other than such portion of Executive's annual salary as\nhas been accrued through the date of his termination of employment and\nreimbursement of expenses pursuant to Section 4 hereof.\n\n            (e) If Executive shall die during the term of his employment\nhereunder, this Agreement shall terminate immediately. In such event, the estate\nof Executive shall thereupon be entitled to receive such portion of Executive's\nannual salary as has been accrued through the date of his death and such bonus,\nif any, as the Board of Directors of BTG in its sole discretion may determine to\naward taking into account Executive's contributions to the Company prior to his\ndeath. If Executive's death shall occur while he is on Company business, the\nestate of Executive shall be entitled to receive, in addition to the other\namounts set forth in this subsection (e), an amount equal to one-half his then\nannual salary.\n\n            (f) Upon Executive's 'disability', the Company shall have the right\nto terminate Executive's employment. Notwithstanding any inability to perform\nhis duties, Executive shall be entitled to receive his compensation as provided\nherein until the termination of his employment for disability. Any termination\npursuant to this subsection (f) shall be effective on the date 30 days after\nwhich Executive shall have received written notice of the Company's election to\nterminate.\n\n            (g) Notwithstanding any provision to the contrary contained herein,\nin the event that Executive's employment is terminated by the Company at any\ntime for any reason other than justifiable cause, disability or death, or in the\nevent the Company shall fail to renew this Agreement at any time within two\nyears following the effective date of a Change in Control of BTG, the Company\nshall pay to Executive as severance, in full satisfaction and in lieu of any and\nall other payments due and owing to Executive under the terms of this Agreement\n(other than any payments constituting reimbursement of expenses pursuant to\nSection 4 hereof), an amount equal to the greater of (i) one year's salary plus\nExecutive's most recent bonus, if any, (ii) the product of one month's salary\nplus 1\/12 of Executive's most recently declared bonus multiplied by the number\nof years Executive has been employed by the Company or (iii) the amounts\nExecutive is entitled to receive under applicable law, it being understood and\nagreed that payments received by Executive pursuant to Directors Insurance and\nsimilar programs in Israel shall reduce the amounts the Company is required to\npay Executive pursuant to this sentence. As used in this Agreement, a 'Change in\nControl of BTG' shall be deemed to occur if (i) there shall be consummated (x)\nany consolidation or merger of BTG in which BTG is not the continuing or\nsurviving corporation or pursuant to which shares of BTG's Common Stock would be\nconverted into cash, securities or other property, other than a merger of BTG in\nwhich the holders of BTG Common Stock immediately prior to the merger have the\nsame proportionate ownership of common stock of the surviving corporation\nimmediately after the merger, or (y) any sale, lease, exchange or other transfer\n(in one transaction or a series of related transactions) of all, or\nsubstantially all, of the assets of BTG, or (ii) the stockholders of BTG shall\n\n\n                                       5-\n\n\napprove any plan or proposal for liquidation or dissolution of BTG, or (iii) any\nperson (as such term is used in Sections 13(d) and 14(d)(2) of the Securities\nExchange Act of 1934, as amended (the 'Exchange Act')), shall become the\nbeneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of\n40% or more of BTG's outstanding Common Stock other than pursuant to a plan or\narrangement entered into by such person and BTG, or (iv) during any period of\ntwo consecutive years, individuals who at the beginning of such period\nconstitute the entire Board of Directors of BTG shall cease for any reason to\nconstitute a majority thereof unless the election, or the nomination for\nelection by BTG's stockholders, of each new director was approved by a vote of\nat least two- thirds of the directors then still in office who were directors at\nthe beginning of the period.\n\n            (h) Executive may terminate his employment at any time upon 30 days'\nprior written notice to the Company. Upon Executive's termination of his\nemployment hereunder, this Agreement (other than Sections 8, 10, 11, 12 and 13,\nwhich shall survive) shall terminate immediately. In such event, Executive shall\nbe entitled to receive such portion of Executive's annual salary as has been\naccrued to date. Executive shall be entitled to reimbursement of expenses\npursuant to Section 4 hereof and to participate in the Company's benefit plans\nto the extent participation by former employees is required by law or permitted\nby such plans, with the expense of such participation to be as specified in such\nplans for former employees.\n\n            (i) Upon termination of Executive's employment for any reason other\nthan justifiable cause (including termination by Executive), Executive shall be\nentitled to all funds contributed by BTG-ISRAEL on his behalf for Directors\ninsurance' (subject to clause (g) above) and Keren Hishtalmut.\n\n      9. REPRESENTATIONS AND AGREEMENTS OF EXECUTIVE.\n\n            Executive represents and warrants that he is free to enter into this\nAgreement and to perform the duties required hereunder, and that there are no\nemployment contracts or understandings, restrictive covenants or other\nrestrictions, whether written or oral, preventing the performance of his duties\nhereunder or requiring him to perform employment, consulting, business related\nor similar duties for any other person.\n\n      10. NON-COMPETITION.\n\n            (a) Executive agrees that during his employment by the Company and\nfor a period of one (1) year following the termination of Executive's employment\nhereunder, other than by reason of the Company's election not to renew this\nAgreement (the 'Non-Competitive Period'), Executive shall not, directly or\nindirectly, as owner, partner, joint venturer, stockholder, employee, broker,\nagent, principal, trustee, corporate officer, director, licensor, or in any\ncapacity whatsoever engage in, become financially interested in, be employed by,\nrender any consultation or business advice with respect to, or have any\nconnection with, any business engaged in the research, development, testing,\ndesign, manufacture, sale, lease, marketing, utilization or exploitation of any\nproducts or services \n\n\n                                       6-\n\n\nwhich are designed for the same purpose as, are similar to, or are otherwise\ncompetitive with, products or services of the Company or any of its\nsubsidiaries, in any geographic area where, at the time of the termination of\nhis employment hereunder, the business of the Company or any of its subsidiaries\nwas being conducted or was proposed to be conducted in any manner whatsoever;\nprovided, however, that Executive may own any securities of any corporation\nwhich is engaged in such business and is publicly owned and traded but in an\namount not to exceed at any one time one percent (1%) of any class of stock or\nsecurities of such corporation. In addition, Executive shall not, directly or\nindirectly, request or cause any collaborative partners, universities,\ngovernmental agencies, contracting parties, suppliers or customers with whom the\nCompany or any of its subsidiaries has a business relationship to cancel or\nterminate any such business relationship with the Company or any of its\nsubsidiaries or solicit, interfere with or entice from the Company any employee\n(or former employee) of the Company.\n\n            (b) If any portion of the restrictions set forth in this Section 10\nshould, for any reason whatsoever, be declared invalid by a court of competent\njurisdiction, the validity or enforceability of the remainder of such\nrestrictions shall not thereby be adversely affected.\n\n            (c) Executive acknowledges that the Company conducts business on a\nworld-wide basis, that its sales and marketing prospects are for continued\nexpansion into world markets and that, therefore, the territorial and time\nlimitations set forth in this Section 10 are reasonable and properly required\nfor the adequate protection of the business of the Company and its subsidiaries.\nIn the event any such territorial or time limitation is deemed to be\nunreasonable by a court of competent jurisdiction, Executive agrees to the\nreduction of the territorial or time limitation to the area or period which such\ncourt shall deem reasonable.\n\n            (d) The existence of any claim or cause of action by Executive\nagainst the Company or any subsidiary shall not constitute a defense to the\nenforcement by the Company or any subsidiary of the foregoing restrictive\ncovenants, but such claim or cause of action shall be litigated separately.\n\n      11. INVENTIONS AND DISCOVERIES.\n\n            (a) Executive shall promptly and fully disclose to the Company, and\nwith all necessary detail for a complete understanding of the same, all\ndevelopments, know-how, discoveries, inventions, improvements, concepts, ideas,\nwritings, formulae, processes and methods of a financial or other nature\n(whether copyrightable, patentable or otherwise) made, received, conceived,\nacquired or written during working hours, or otherwise, by Executive (whether or\nnot at the request or upon the suggestion of the Company) during the period of\nhis employment with, or rendering of advisory or consulting services to, the\nCompany or any of its subsidiaries, solely or jointly with others, in or\nrelating to any activities of the Company or its subsidiaries known to him as a\nconsequence of his employment or the rendering of advisory and consulting\nservices hereunder (collectively the 'Subject Matter').\n\n\n                                       7-\n\n\n            (b) Executive hereby assigns and transfers, and agrees to assign and\ntransfer, to the Company, all his rights, title and interest in and to the\nSubject Matter, and Executive further agrees to deliver to the Company any and\nall drawings, notes, specifications and data relating to the Subject Matter, and\nto execute, acknowledge and deliver all such further papers, including\napplications for copyrights or patents, as may be necessary to obtain copyrights\nand patents for any thereof in any and all countries and to vest title thereto\nto the Company. Executive shall assist the Company in obtaining such copyrights\nor patents during the term of this Agreement, and any time thereafter on\nreasonable notice and at mutually convenient times, and Executive agrees to\ntestify in any prosecution or litigation involving any of the Subject Matter;\nprovided, however, that Executive shall be compensated in a timely manner at the\nrate of $100.00 per hour (with a minimum of $500 per day), plus out-of-pocket\nexpenses incurred in rendering such assistance or giving or preparing to give\nsuch testimony if it is required after termination of his employment hereunder.\n\n      12. NON-DISCLOSURE OF CONFIDENTIAL INFORMATION.\n\n            (a) Executive shall not, during the term of this Agreement, or at\nany time following termination of this Agreement, directly or indirectly,\ndisclose, permit to be known or make accessible (other than as is required in\nthe regular course of his duties or is required by law (in which case Executive\nshall give the Company prior written notice of such required disclosure) or with\nthe prior written consent of the Board of Directors of BTG), to any person, firm\nor corporation, any confidential information acquired by him during the course\nof, or as an incident to, his employment or the rendering of his advisory or\nconsulting services hereunder, relating to the Company or any of its\nsubsidiaries, the directors of the Company or its subsidiaries, any client of\nthe Company or any of its subsidiaries, or any corporation, partnership or other\nentity owned or controlled, directly or indirectly, by any of the foregoing, or\nin which any of the foregoing has a beneficial interest, including, but not\nlimited to, the business affairs of each of the foregoing. Such confidential\ninformation shall include, but shall not be limited to, proprietary technology,\ntrade secrets, patented processes, research and development data, know-how,\nmarket studies and forecasts, competitive analyses, pricing policies, employee\nlists, personnel policies, the substance of agreements with customers and\nothers, marketing or dealership arrangements, servicing and training programs\nand arrangements, customer lists and any other documents embodying such\nconfidential information. This confidentiality obligation shall not apply to any\nconfidential information which thereafter becomes publicly available other than\npursuant to a breach of this Section 12(a) by Executive.\n\n            (b) All information and documents relating to the Company and its\naffiliates as hereinabove described (or other business affairs) shall be the\nexclusive property of the Company, and Executive shall use commercially\nreasonable best efforts to prevent any publication or disclosure thereof. Upon\ntermination of Executive's employment with the Company, all documents, records,\nreports, writings and other similar documents containing confidential\ninformation, including copies thereof, then in Executive's possession or control\nshall be returned and left with the Company.\n\n\n                                       8-\n\n\n      13. SPECIFIC PERFORMANCE.\n\n            Executive agrees that if he breaches, or threatens to commit a\nbreach of, any of the provisions of Sections 10, 11 or 12 (the 'Restrictive\nCovenants'), the Company shall have, in addition to, and not in lieu of, any\nother rights and remedies available to the Company under law and in equity, the\nright to have the Restrictive Covenants specifically enforced by any court of\ncompetent jurisdiction, it being agreed that any breach or threatened breach of\nthe Restrictive Covenants would cause irreparable injury to the Company and that\nmoney damages would not provide an adequate remedy to the Company.\nNotwithstanding the foregoing, nothing herein shall constitute a waiver by\nExecutive of his right to contest whether a breach or threatened breach of any\nRestrictive Covenant has occurred.\n\n      14. AMENDMENT OR ALTERATION.\n\n            No amendment or alteration of the terms of this Agreement shall be\nvalid unless made in writing and signed by both of the parties hereto.\n\n      15. GOVERNING LAW.\n\n            This Agreement shall be governed by the laws of the State of New\nJersey applicable to agreements made and to be performed therein.\n\n      16. SEVERABILITY.\n\n            The holding of any provision of this Agreement to be invalid or\nunenforceable by a court of competent jurisdiction shall not affect any other\nprovision of this Agreement, which shall remain in full force and effect.\n\n      17. NOTICES.\n\n            Any notices required or permitted to be given hereunder shall be\nsufficient if in writing, and if delivered by hand, or sent by certified mail,\nreturn receipt requested, to the addresses set forth above or such other address\nas either party may from time to time designate in writing to the other, and\nshall be deemed given as of the date of the delivery or mailing.\n\n      18. WAIVER OR BREACH.\n\n            It is agreed that a waiver by either party of a breach of any\nprovision of this Agreement shall not operate, or be construed, as a waiver of\nany subsequent breach by that same party.\n\n\n                                       9-\n\n\n      19. ENTIRE AGREEMENT AND BINDING EFFECT.\n\n            This Agreement contains the entire agreement of the parties with\nrespect to the subject matter hereof, shall be binding upon and inure to the\nbenefit of the parties hereto and their respective legal representatives, heirs,\ndistributors, successors and assigns. Notwithstanding the foregoing, all prior\nagreements between Executive and the Company relating to the confidentiality of\ninformation, trade secrets, patents and stock options shall not be affected by\nthis Agreement.\n\n      20. SURVIVAL.\n\n            The termination of Executive's employment hereunder or the\nexpiration of this Agreement shall not affect the enforceability of Sections 8,\n10, 11, 12 and 13 hereof.\n\n      21. FURTHER ASSURANCES.\n\n            The parties agree to execute and deliver all such further documents,\nagreements and instruments and take such other and further action as may be\nnecessary or appropriate to carry out the purposes and intent of this Agreement.\n\n      22. HEADINGS.\n\n            The Section headings appearing in this Agreement are for the\npurposes of easy reference and shall not be considered a part of this Agreement\nor in any way modify, demand or affect its provisions.\n\n                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]\n\n\n                                       10-\n\n\n\n            IN WITNESS WHEREOF, the parties hereto have executed this Agreement\nas of the date and year first above written.\n\n\n                                       BIO-TECHNOLOGY GENERAL CORP.\n\n\n                                       By: \/s\/ Sim Fass\n                                           -------------------------------------\n\n\n                                       BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.\n\n\n                                       By: \/s\/ Sim Fass\n                                           -------------------------------------\n\n\n                                       \/s\/ Dov Kanner\n                                       -----------------------------------------\n                                       Dov Kanner\n\n\n                                       11-\n<\/pre>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6900],"corporate_contracts_industries":[9406],"corporate_contracts_types":[9539,9544],"class_list":["post-38974","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-bio-technology-general-corp","corporate_contracts_industries-drugs__botanical","corporate_contracts_types-compensation","corporate_contracts_types-compensation__employment"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/38974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=38974"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=38974"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=38974"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=38974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}